Hepatox
Store data observed · From public App Store data · How we score apps
- Medical
- App Store
- United States
- —0 ratings
- Paid $3.99
- Updated
- Observed
Ratings
Observed0
Chart position
Observed—Not on the top charts
90-day growth
—not enough history yet
Opportunity score
AI-derived1/100Weak · low confidence
Own Hepatox? Share your real numbers
Your numbers stay private. They only tune MRRBeam's estimates, so every app's figures get more accurate.
Sign in to share them.
Made Hepatox? Add a “Tracked in Medical” badge to your site
About HepatoxObserved
Hepatox is a Medical app by Pierre Chaillet on the United States App Store. Released Dec 21, 2011; last updated Aug 8, 2026 (version 2.1.2). Hepatox costs $3.99 to download.
MRRBeam rates the success of Hepatox 0/100 (early stage).
Hepatox®, a bibliographical database which reviews drug-induced liver injury, was created in 1980 by Michel BIOUR (MD, PhD), and has been monthly updated in accordance with other usual bibliographical databases to the analysis of the references cited in the articles.
- Success score
- 0/100 Early stage
- In Medical
- Outside the top 100
- Chart position
- Not on the top charts
- Developer
- Pierre Chaillet
Loading the full report…
Hepatox: common questions
- What is Hepatox?
- Hepatox is a Medical app developed by Pierre Chaillet, available on the App Store. It was first released on Dec 21, 2011.
- How much does Hepatox cost?
- Hepatox costs $3.99 to download.
- Is Hepatox successful?
- MRRBeam rates the success of Hepatox 0/100 (early stage). The success score combines rating volume, chart position and average rating.
- When was Hepatox last updated?
- Hepatox was last updated on Aug 8, 2026 (version 2.1.2).
- What are alternatives to Hepatox?
- Similar Medical apps tracked by MRRBeam include CVS Health, MyChart, healow, UnitedHealthcare and GoodRx: Prescription Savings.
- Is there room to build a competitor to Hepatox?
- MRRBeam's opportunity score for Hepatox is 1/100. Limited opening: an older app, little observable demand and low price points.